Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Alendronic acid/colecalciferol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alendronic acid 70mg / Colecalciferol 70microgram tablets
0606020Y0AAAAAA
|
Alendronic acid/colecalciferol | Alendronic acid/colecalciferol | Endocrine System | 811 |
|
Fosavance tablets
0606020Y0BBAAAA
|
Fosavance | Alendronic acid/colecalciferol | Endocrine System | 148 |
|
Alendronic acid 70mg / Colecalciferol 140microgram tablets
0606020Y0AAABAB
|
Alendronic acid/colecalciferol | Alendronic acid/colecalciferol | Endocrine System | 24 |
|
Bentexo 70mg/5,600unit tablets
0606020Y0BCAAAB
|
Bentexo | Alendronic acid/colecalciferol | Endocrine System | 18 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.